The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Genomic Cancer Testing-Global Market Insights and Sales Trends 2025
Synopsis
The global Genomic Cancer Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Genomic Cancer Testing in various end use industries. The expanding demands from the Hospitals, Speciality Clinics, Research Institutes and Diagnostics Laboratories, are propelling Genomic Cancer Testing market. Fluorescence In Situ Hybridization, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Polymerase Chain Reaction segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Genomic Cancer Testing market, driven by demand from China, the second largest economy with some signs of stabilising, the Genomic Cancer Testing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Genomic Cancer Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Genomic Cancer Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Genomic Cancer Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Genomic Cancer Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Genomic Cancer Testing covered in this report include Devyser, Agendia, Illumina, Personal Genome Diagnostics, Veracyte, Pacific Biosciences of California, Qiagen, Agilent Technologies and Natera, etc.
The global Genomic Cancer Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Devyser
Agendia
Illumina
Personal Genome Diagnostics
Veracyte
Pacific Biosciences of California
Qiagen
Agilent Technologies
Natera
Bio Rad Laboratories
Myriad Genetics
Global Genomic Cancer Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Genomic Cancer Testing market, Segment by Type:
Fluorescence In Situ Hybridization
Polymerase Chain Reaction
Microarray Technology
Serum Proteomics
Nucleic Acid Sequencing
Global Genomic Cancer Testing market, by Application
Hospitals
Speciality Clinics
Research Institutes
Diagnostics Laboratories
Biopharmaceutical Companies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Genomic Cancer Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Genomic Cancer Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Genomic Cancer Testing in various end use industries. The expanding demands from the Hospitals, Speciality Clinics, Research Institutes and Diagnostics Laboratories, are propelling Genomic Cancer Testing market. Fluorescence In Situ Hybridization, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Polymerase Chain Reaction segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Genomic Cancer Testing market, driven by demand from China, the second largest economy with some signs of stabilising, the Genomic Cancer Testing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Genomic Cancer Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Genomic Cancer Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Genomic Cancer Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Genomic Cancer Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Genomic Cancer Testing covered in this report include Devyser, Agendia, Illumina, Personal Genome Diagnostics, Veracyte, Pacific Biosciences of California, Qiagen, Agilent Technologies and Natera, etc.
The global Genomic Cancer Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Devyser
Agendia
Illumina
Personal Genome Diagnostics
Veracyte
Pacific Biosciences of California
Qiagen
Agilent Technologies
Natera
Bio Rad Laboratories
Myriad Genetics
Global Genomic Cancer Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Genomic Cancer Testing market, Segment by Type:
Fluorescence In Situ Hybridization
Polymerase Chain Reaction
Microarray Technology
Serum Proteomics
Nucleic Acid Sequencing
Global Genomic Cancer Testing market, by Application
Hospitals
Speciality Clinics
Research Institutes
Diagnostics Laboratories
Biopharmaceutical Companies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Genomic Cancer Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Genomic Cancer Testing
1.1 Genomic Cancer Testing Market Overview
1.1.1 Genomic Cancer Testing Product Scope
1.1.2 Genomic Cancer Testing Market Status and Outlook
1.2 Global Genomic Cancer Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Genomic Cancer Testing Market Size by Region (2018-2029)
1.4 Global Genomic Cancer Testing Historic Market Size by Region (2018-2023)
1.5 Global Genomic Cancer Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Genomic Cancer Testing Market Size (2018-2029)
1.6.1 North America Genomic Cancer Testing Market Size (2018-2029)
1.6.2 Europe Genomic Cancer Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Genomic Cancer Testing Market Size (2018-2029)
1.6.4 Latin America Genomic Cancer Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Genomic Cancer Testing Market Size (2018-2029)
2 Genomic Cancer Testing Market by Type
2.1 Introduction
2.1.1 Fluorescence In Situ Hybridization
2.1.2 Polymerase Chain Reaction
2.1.3 Microarray Technology
2.1.4 Serum Proteomics
2.1.5 Nucleic Acid Sequencing
2.2 Global Genomic Cancer Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Genomic Cancer Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Genomic Cancer Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Genomic Cancer Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Genomic Cancer Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Genomic Cancer Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Genomic Cancer Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Genomic Cancer Testing Revenue Breakdown by Type (2018-2029)
3 Genomic Cancer Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Speciality Clinics
3.1.3 Research Institutes
3.1.4 Diagnostics Laboratories
3.1.5 Biopharmaceutical Companies
3.2 Global Genomic Cancer Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Genomic Cancer Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Genomic Cancer Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Genomic Cancer Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Genomic Cancer Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Genomic Cancer Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Genomic Cancer Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Genomic Cancer Testing Revenue Breakdown by Application (2018-2029)
4 Genomic Cancer Testing Competition Analysis by Players
4.1 Global Genomic Cancer Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Genomic Cancer Testing as of 2022)
4.3 Date of Key Players Enter into Genomic Cancer Testing Market
4.4 Global Top Players Genomic Cancer Testing Headquarters and Area Served
4.5 Key Players Genomic Cancer Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Genomic Cancer Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Devyser
5.1.1 Devyser Profile
5.1.2 Devyser Main Business
5.1.3 Devyser Genomic Cancer Testing Products, Services and Solutions
5.1.4 Devyser Genomic Cancer Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Devyser Recent Developments
5.2 Agendia
5.2.1 Agendia Profile
5.2.2 Agendia Main Business
5.2.3 Agendia Genomic Cancer Testing Products, Services and Solutions
5.2.4 Agendia Genomic Cancer Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Agendia Recent Developments
5.3 Illumina
5.3.1 Illumina Profile
5.3.2 Illumina Main Business
5.3.3 Illumina Genomic Cancer Testing Products, Services and Solutions
5.3.4 Illumina Genomic Cancer Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Personal Genome Diagnostics Recent Developments
5.4 Personal Genome Diagnostics
5.4.1 Personal Genome Diagnostics Profile
5.4.2 Personal Genome Diagnostics Main Business
5.4.3 Personal Genome Diagnostics Genomic Cancer Testing Products, Services and Solutions
5.4.4 Personal Genome Diagnostics Genomic Cancer Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Personal Genome Diagnostics Recent Developments
5.5 Veracyte
5.5.1 Veracyte Profile
5.5.2 Veracyte Main Business
5.5.3 Veracyte Genomic Cancer Testing Products, Services and Solutions
5.5.4 Veracyte Genomic Cancer Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Veracyte Recent Developments
5.6 Pacific Biosciences of California
5.6.1 Pacific Biosciences of California Profile
5.6.2 Pacific Biosciences of California Main Business
5.6.3 Pacific Biosciences of California Genomic Cancer Testing Products, Services and Solutions
5.6.4 Pacific Biosciences of California Genomic Cancer Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Pacific Biosciences of California Recent Developments
5.7 Qiagen
5.7.1 Qiagen Profile
5.7.2 Qiagen Main Business
5.7.3 Qiagen Genomic Cancer Testing Products, Services and Solutions
5.7.4 Qiagen Genomic Cancer Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Qiagen Recent Developments
5.8 Agilent Technologies
5.8.1 Agilent Technologies Profile
5.8.2 Agilent Technologies Main Business
5.8.3 Agilent Technologies Genomic Cancer Testing Products, Services and Solutions
5.8.4 Agilent Technologies Genomic Cancer Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Agilent Technologies Recent Developments
5.9 Natera
5.9.1 Natera Profile
5.9.2 Natera Main Business
5.9.3 Natera Genomic Cancer Testing Products, Services and Solutions
5.9.4 Natera Genomic Cancer Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Natera Recent Developments
5.10 Bio Rad Laboratories
5.10.1 Bio Rad Laboratories Profile
5.10.2 Bio Rad Laboratories Main Business
5.10.3 Bio Rad Laboratories Genomic Cancer Testing Products, Services and Solutions
5.10.4 Bio Rad Laboratories Genomic Cancer Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Bio Rad Laboratories Recent Developments
5.11 Myriad Genetics
5.11.1 Myriad Genetics Profile
5.11.2 Myriad Genetics Main Business
5.11.3 Myriad Genetics Genomic Cancer Testing Products, Services and Solutions
5.11.4 Myriad Genetics Genomic Cancer Testing Revenue (US$ Million) & (2018-2023)
5.11.5 Myriad Genetics Recent Developments
6 North America
6.1 North America Genomic Cancer Testing Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Genomic Cancer Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Genomic Cancer Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Genomic Cancer Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Genomic Cancer Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Genomic Cancer Testing Market Dynamics
11.1 Genomic Cancer Testing Industry Trends
11.2 Genomic Cancer Testing Market Drivers
11.3 Genomic Cancer Testing Market Challenges
11.4 Genomic Cancer Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
